RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can extra antibodies shield myeloma patients from infections during powerful new treatment?
Disease control Recruiting nowThis study looks at multiple myeloma patients who are receiving a type of immunotherapy called a BCMA-directed T cell engager. These treatments can weaken the immune system and raise the risk of serious infections. The trial will compare two levels of immunoglobulin (antibody) su…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE4 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 26, 2026 06:42 UTC
-
New hope for Tough-to-Treat myeloma: early trial of OPN-6602 begins
Disease control Recruiting nowThis early-phase study tests a new drug called OPN-6602, given alone or with another drug (dexamethasone), in people whose multiple myeloma has returned or stopped responding to at least three prior treatments. The main goal is to check the drug's safety and find the right dose. …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Opna Bio LLC • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
Promising 4-Drug cocktail targets Hard-to-Treat myeloma
Disease control Recruiting nowThis study tests a new combination of four drugs (iberdomide, daratumumab, carfilzomib, and dexamethasone) in 30 people whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to see if this combo can shrink the cancer and keep it from coming ba…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Benjamin T Diamond, MD • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for Tough-to-Treat myeloma: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of three drugs—talquetamab, iberdomide, and dexamethasone—in people with multiple myeloma that has returned or stopped responding to other treatments. The goal is to find the safest dose and check for side effects. About 32 adults will take part in …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Alfred Chung, MD • Aim: Disease control
Last updated May 22, 2026 13:54 UTC